Cite
HARVARD Citation
Joly, P. et al. (2017). First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. Lancet. 389 (10083), pp. 2031-2040. [Online].